Complimentary Learning Level: Intermediate Session Length: 1 hour Per- and polyfluoroalkyl substances (PFAS) have become a significant concern in the pharmaceutical industry due to their persistence in the environment...
Learning Level: Intermediate -
The SARS-CoV-2 worldwide pandemic has presented a significant challenge to business continuity for pharmaceutical manufacturing. It has led to Industry re-assessing the virus control framework, and in particular, any challenges that this may present to the mitigations currently in place. This presentation will focus on the SARS-CoV-2 situation and factors to be assessed in a GMP Biopharmaceutical manufacturing facility and whether they present a secure virus mitigation strategy to protect the product from contamination from this and other viruses.
- The factors involved in the virus control framework for a Biopharmaceutical manufacturing facility with reference to ICH Q5A.
- The planning activities required in order to prepare for a novel virus challenge to manufacturing facilities.
- Ongoing virus risk management and mitigations.
Speaker
Subscribe to your ISPE YouTube Channel
& Click the bell for notifications.
& Click the bell for notifications.
Past Webinars
Join us for the complimentary ISPE Member Orientation and Benefits webinar to unlock your membership's full potential. Gain valuable insights into leveraging your ISPE profile, exploring exciting involvement opportunities...
Automation Isn’t Automatic: Strategy for Designing and Building a Fully Autonomous Laboratory Complimentary Learning Level: Intermediate Session Length: 1.5 hours Designing a fully automated lab requires insight and detailed...